Search Within
Document Type
209-288-4
Applied Filters:
Keyword:'209-288-4'
Showing 1-28 of 28 results for "209-288-4" within Technical Documents
Data Sheet - E2759
al., 257, 5333 (1982).
2. Olander, J. et al., In Vitro, 16, 209 (1980).
3. Folkman, J., and Haudenschild, C., Nature, 288,
551 (1980)
4. Evans, C.H., and DiPaolo, J.A., Natl. Cancer Inst.,
68
Data Sheet - E0760
257, 5333 (19-82).
2. Olander, J. et al., In Vitro, 16, 209 (1980).
3. Folkman, J., and Haudenschild, C., Nature, 288,
551 (1980).
4. Evans, C.H., and DiPaolo, J.A., Journal of the
National
Product Information Sheet - T1512
(1996).
16. Thienpoint, D. et al., Nature, 209, 1084-1086
(1966).
17. Rousseau, R. et al., Eur. J. Drug Met.
Pharmacokinet., 6, 281-288 (1981).
N
S
Data Sheet - F9925
C-Terminal is produced in rabbit using
as immunogen a synthetic peptide corresponding to
amino acids 191-209 of the C-terminal of
human FLIPδ/FLIPS1.
Anti-FLIPγ/δ, C-Terminal detects FLIPγ (35 kDa) and
XP725 Antibody Number-Lot Number 071M4826
253 254 255 256 277 278 279 280
3.5 209 210 211 212 233 234 235 236 257 258 259 260 281 282 283 284
3.6 213 214 215 216 237 238 239 240 261 262 263 264 285 286 287 288
4.1
Data Sheet - N8129
Biophys.,
82(2), 288-299 (1959).
3. Passonneau, J.V., and Lowry, O.H., Enzymatic
Analysis. A Practical Guide. Humana Press
(Totowa, NJ), pp. 9-10 (1993).
4. Bergmeyer et al., Vol. 4, pp. 2066-2072
LABORATORY NOTEBOOK ISSUANCE PAGE
106.42(1)
Phosphorus P 15 30.973 762(2)
Platinum Pt 78 195.084(9)
Plutonium Pu 94 [244]
Polonium Po 84 [209]
Potassium K 19 39.0983(1)
Praseodymium Pr 59 140.907 65(2)
Promethium Pm 61 [145]
Protactinium Pa
LABORATORY NOTEBOOK ISSUANCE PAGE
106.42(1)
Phosphorus P 15 30.973 762(2)
Platinum Pt 78 195.084(9)
Plutonium Pu 94 [244]
Polonium Po 84 [209]
Potassium K 19 39.0983(1)
Praseodymium Pr 59 140.907 65(2)
Promethium Pm 61 [145]
Protactinium Pa
LABORATORY NOTEBOOK ISSUANCE PAGE
106.42(1)
Phosphorus P 15 30.973 762(2)
Platinum Pt 78 195.084(9)
Plutonium Pu 94 [244]
Polonium Po 84 [209]
Potassium K 19 39.0983(1)
Praseodymium Pr 59 140.907 65(2)
Promethium Pm 61 [145]
Protactinium Pa
PKH Dye Reference Guide
279-288.
152. Wilbanks GA, Streilein JW: Macrophages capable
of inducing anterior chamber associated immune
deviation demonstrate spleen-seeking migratory
properties. Reg.Immunol. 1992; 4: 130
Article: Selection of clarification methods for improved downstream performance and economics
of virus-like par ticles
f rom Saccharomyces cerevisiae. J Chem Technol Biotechnol, 2010; 85(2): 209–15.
ht tp://dx.doi.org/10.1002/jc tb.2290.
[28] Singh N, Pizzelli K, Romero JK, Chrostowski J, Evangelist
Corticotropin-Releasing Factor Receptor Antagonists- Potential Novel Therapies for Human Disease
al., Neuropsychopharmacology, 15, 288-295 (1996).
110. Goeders, N.E., J. Pharmacol. Exp. Ther., 301, 785-789 (2002).
111. Sarnyai, Z., et al., Pharmacol. Rev., 53, 209-243 (2001).
112. Koob, G. F., Ann.
Perfection in every dimension 2014. Inorganic reagents Catalogue
More information
www.emdmillipore.com/ph-indicator-selector
288
The pH-Indicator-Selector
pH-indicators pH 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14
Malachite green oxalate green
XP725 Antibody List Lot 089K4791
705694.2 y n/d n/d
208 Cytokeratin peptide 13 C0791 3860 KRT13 M NP_002265.2 ,NP_705694.2 y n/d n/d
209 Cytokeratin Peptide 17 C9179 3872 KRT17 M NP_000413.1 y n/d y
204 Cytokeratin CK5 C7785 3875 KRT18
XP725 Antibody List Lot 129K4831
705694.2 y n/d n/d
208 Cytokeratin peptide 13 C0791 3860 KRT13 M NP_002265.2 ,NP_705694.2 y n/d n/d
209 Cytokeratin Peptide 17 C9179 3872 KRT17 M NP_000413.1 y n/d y
204 Cytokeratin CK5 C7785 3875 KRT18
XP725 Antibody List Lot 129K4830
705694.2 y n/d n/d
208 Cytokeratin peptide 13 C0791 3860 KRT13 M NP_002265.2 ,NP_705694.2 y n/d n/d
209 Cytokeratin Peptide 17 C9179 3872 KRT17 M NP_000413.1 y n/d y
204 Cytokeratin CK5 C7785 3875 KRT18
inNovations Newsletter #16
known amounts of S•Tag Standard.
Construct Fraction pmol/ml µg/ml % in fraction
GST soluble 116 209 65.1
GST insoluble 62.2 112 34.9
NusA soluble 33.2 121 74.7
NusA insoluble 11.2 41 25.3
b-gal
Hallmarks of Cancer - Solutions for life science research
peptides derived
from mitochondrial proteins
Bak and Bax.
The Hallmark &
Drug Development
PTC-209, a research compound,
was observed to induce
apoptosis in leukemia and
colorectal cancer-initiating
List of Antibodies
C7034 M y n/d n/d
207 Cytokeratin 8.13 C6909 M y n/d n/d
208 Cytokeratin peptide 13 C0791 M y n/d n/d
209 Cytokeratin Peptide 17 C9179 M y n/d y
210 Cytokeratin peptide 18 C1399 M y n/d n/d
211 Cytokeratin
XP725 Worksheet for Lot Number 071M4826
1 2 3 Calponin C2687
204 2 1 2 4 Calponin C2687
205 2 1 2 5 Calreticulin C4606
206 2 1 2 6 Calreticulin C4606
207 2 1 2 7 Calretinin C7479
208 2 1 2 8 Calretinin C7479
209 2 1 3 1 Claspin
Halal Certificate
W268100 A76428 HC-24SI7886
288. 4-METHYLNONANOIC ACID 97% W357405 A22044 HC-24SIBI21
289. 4-METHYLPENTANOIC ACID 98%, FCC, FG W346306 A46644 HC-24SIXI78
290. 4-METHYLPENTYL 4-METHYLVALERATE W474900 C29023
Halal Certificate
W268100 A76428 HC-22SI7Y84
288. 4-METHYLNONANOIC ACID 97% W357405 A22044 HC-22SIAK19
289. 4-METHYLPENTANOIC ACID 98%, FCC, FG W346306 A46644 HC-22SIH576
290. 4-METHYLPENTYL 4-METHYLVALERATE W474900 C29023
XP725 Antibody List
,NP_005546.2,NP_00 M y n/d n/d
208 Cytokeratin peptide 13 C0791 3860 KRT13 NP_705694.2 M y n/d n/d
209 Cytokeratin Peptide 17 C9179 3872 KRT17 NP_000413.1 M y n/d y
210 Cytokeratin peptide 18 C1399 3875
XP725 Antibody List 013M4793
_006112.3,NP_00041 M y n/d n/d
208 Cytokeratin peptide 13 C0791 3860 KRT13 NP_705694.2 M y n/d n/d
209 Cytokeratin Peptide 17 C9179 3872 KRT17 NP_000413.1 M y n/d y
210 Cytokeratin peptide 18 C1399 3875
Chrombook 2015 - The world of chromatography in your hands
endcapped
Chromatographic conditions
0
1
2
3
4
5
6
Intensity
[x=107]
0 2 4 6 8 10 12
Time [min]
EIC 209; 253; 507 – All MS
EIC 197; 241;
Cytoskeletal Signaling Antibodies, Reagents and Kits
Pur M IgG1κ 100 µg 05-668
Polyclonal Antibody
phospho-SHC (Tyr239) H WB ELISA Rb IgG 200 µL 07-209
phospho-SHC (Tyr317) H M WB Rb IgG 200 µL 07-206
SHC H M R Po WB IP IH
Inhibitor Sourcebook 3rd Edition
Science 288, 1425.
Zhou, B-B., et al. 2000. Nature 408, 433.
Checkpoint kinase Inhibitors
Product Cat. No. Comments Size
Chk2 Inhibitor 220485 {5-(2-Amino-5-oxo-1,5-dihydroimidazol-4-ylidine)
Lab Notebook Guidelines
106.42(1)
Phosphorus P 15 30.973 762(2)
Platinum Pt 78 195.084(9)
Plutonium Pu 94 [244]
Polonium Po 84 [209]
Potassium K 19 39.0983(1)
Praseodymium Pr 59 140.907 65(2)
Promethium Pm 61 [145]
Protactinium Pa